Streetbeat News

Price Targets

AXP

Monness, Crespi, Hardt has maintained a Buy rating on American Express and raised its price target from $265 to $300, indicating confidence in the company's future performance.

Portfolio Pulse from Benzinga Newsdesk

October 14, 2024 | 3:32 pm

SLE

Maxim Group analyst Jack Vander Aarde maintains a Buy rating on Super League Enterprise (NASDAQ:SLE) but lowers the price target from $4 to $3.

Portfolio Pulse from Benzinga Newsdesk

October 14, 2024 | 3:31 pm

OXY

Financial giants are showing a bullish trend on Occidental Petroleum (NYSE:OXY) with 24 unusual options trades, 54% being bullish. The price target is between $30.0 and $60.0. Analysts have mixed ratings, with price targets ranging from $55 to $72. OXY's current price is $54.17, down 1.07%.

Portfolio Pulse from Benzinga Insights

October 14, 2024 | 3:30 pm

PEN

Penumbra shares rose following the completion of enrollment in its THUNDER clinical study for acute ischemic stroke. Truist Securities maintained a Buy rating and increased the price target from $200 to $235.

Portfolio Pulse from Benzinga Newsdesk

October 14, 2024 | 3:29 pm

CBOE

Oppenheimer analyst Owen Lau has maintained an 'Outperform' rating on Cboe Global Markets and raised the price target from $209 to $227.

Portfolio Pulse from Benzinga Newsdesk

October 14, 2024 | 3:26 pm

AVNT

Oppenheimer analyst Kristen Owen has maintained an 'Outperform' rating on Avient (NYSE:AVNT) and raised the price target from $53 to $58.

Portfolio Pulse from Benzinga Newsdesk

October 14, 2024 | 3:25 pm

DECK

TD Cowen analyst John Kernan maintains a Buy rating on Deckers Outdoor (NYSE:DECK) and raises the price target from $176 to $178.

Portfolio Pulse from Benzinga Newsdesk

October 14, 2024 | 3:22 pm

JACK

Loop Capital has maintained a Buy rating on Jack In The Box but lowered its price target from $87 to $70.

Portfolio Pulse from Benzinga Newsdesk

October 14, 2024 | 3:21 pm

SKX

TD Cowen analyst John Kernan maintains a Buy rating on Skechers USA (NYSE:SKX) but lowers the price target from $78 to $76.

Portfolio Pulse from Benzinga Newsdesk

October 14, 2024 | 3:16 pm

MPW

Deep-pocketed investors are showing significant interest in Medical Properties Trust (NYSE:MPW), with a notable increase in options activity. The sentiment is mixed, with 58% bullish and 41% bearish. The stock is currently down 5.47% at $4.49, and RSI suggests it may be oversold.

Portfolio Pulse from Benzinga Insights

October 14, 2024 | 3:15 pm